doi: 10.3389/fnut.2025.1550880 Received 03 January 2025 Accepted 07 March 2025 Published 24 March 2025 Volume 12 - 2025 Edited by Wenlong Wang, Pingdingshan University, China Reviewed by Zheng Ruan, Nanchang University, China Qian Jiang, Hunan Agricultural University, China Updates Copyright 2025 Mo, Ma, Li, Song, Song and Wang
These findings suggest that DSIP, especially when combined with CBBBP, effectively mitigates PCPA-induced changes in sucrose preference, offering valuable insights into potential treatments for hedonistic behavior modifications in clinical settings ( The research presented in Figures 6AD explores the impact of various treatments on biochemical biomarkers associated with stress and sleep disorders, highlighting the differential efficacy of these interventions in modulating serum levels of melatonin, serotonin, dopamine, and glutamate among different groups
Abaloparatide, Pasireotide, TeduglutideDistinctive, Meaningful Tools Talking about these peptides, one must attend to what makes each unique
Next Steps Please take consultation for better evaluation and best Treatment